Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

BUY
$63.15 - $71.6 $32,964 - $37,375
522 Added 12.56%
4,677 $325,000
Q4 2022

Jan 10, 2023

BUY
$54.21 - $70.44 $225,242 - $292,678
4,155 New
4,155 $282,000
Q2 2022

Jul 29, 2022

BUY
$59.26 - $71.14 $197,987 - $237,678
3,341 New
3,341 $221,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Single Point Partners, LLC Portfolio

Follow Single Point Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Single Point Partners, LLC with notifications on news.